Disco Pharmaceuticals
Disco Pharmaceuticals is a cancer Surface Protein Identification founded in 2022.
1
Funding Rounds
$22.0m
Money raised
Funding series
Funding Series Analysis
The company Disco Pharmaceuticals has raised a total of $22m in funding over 1 rounds.
Key Insights:
- Disco Pharmaceuticals January 2024 Seed Funding Round: $22m
Disco Pharmaceuticals January 2024 Seed Funding Round
$22m